Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT02831751Phase 2Completed
Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults
Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more
Principalinvestigator

Research Network

Collaboration Network

18 collaborators·60 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Centre de Recherche St-Louis, Quebec, Quebec, Canada

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Brandon J Essink, MD

Meridian Clinical Research, Omaha (NE), USA

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Guy Tellier, MD

Omnispec Clinical Research Inc, Mirabel, Canada

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Suchet R Patel, MD

Regional Clinical Research (RCR), Endwell (NY), USA

Moderately Similar
2 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Trevor Wesson, MD

Diex Research Montreal, Montreal, Canada

Moderately Similar
2 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Gérald Vallières, MD

Manna Research, Lévis, Canada

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Paul Bradley, MD

Meridian Clinical Research, Savannah (GA), USA

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Deepen Patel, MD

Topstone Research, Toronto, Canada

Moderately Similar
2 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

David J Seiden, MD

Broward Research Group (BRG), Hollywood (FL), USA

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Diane R Krieger, MD

Miami Research Associates (MRA), Miami (FL), USA

Moderately Similar
1 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Michael Libman, MD

McGill University Health Center - Vaccine Study Center (MUHC), Montreal, Canada

Moderately Similar
2 trials

Shared therapeutic areas:

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more

Worked with same sponsors:

Medicago
Collaborated on 1 trial
Similarity Score44%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT02831751Phase 2PrincipalInvestigator

Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly Adults

Respiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus Infections+1 more
Completed

All 1 trials loaded